Refining Our Approaches to Cataract and Refractive Surgery
-
By
-
Lisa K. Feulner, MD, PhD
-
April 1, 2025
-
2 min
By
Lisa K. Feulner, MD, PhD
April 1, 2025
by Lisa K. Feulner, MD, PhD
April 1, 2025
At ARVO 2026, Arshad M. Khanani, MD, MA, FASRS, presented phase 2 data on vamikibart, an IL-6 inhibitor, in diabetic macular edema.
by Arshad M. Khanani, MD, MA, FASRS, Arshad M. Khanani, MD, MA, FASRS
May 1, 2026
Iraqi-born ophthalmologist Hasan Chichan reflects on bridging the divide between modern retina care and humanitarian medicine
May 26, 2026
Should refractive surgery precision always have to come at a price? Evaluating cost, consistency, and learning curves in astigmatism correction
April 27, 2026